What is CVE-2018-18976?

CVE-2018-18976 is a medium-severity vulnerability in Ascensia Contour Diabetes, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 5.3/10. Published 2019-05-06.

How severe is CVE-2018-18976?

Medium severity. CVSS v3 base score is 5.3 out of 10.

Auth bypass in Ascensia Contour Diabetes

CVE-2018-18976

An issue was discovered in the Ascensia Contour NEXT ONE application for iOS and Android before 2019-01-15. An attacker may retrieve encrypted medical information of any user of the Ascensia cloud platform by performing Direct Object References with a series of user ID values. (This information can be decrypted through a different vulnerability.)

Vulnerability class: IDOR (Insecure Direct Object Reference)

EPSS: 0.011 (63.4th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N.

Affected products

Ascensia Contour_diabetes
N/a — versions n/a

Weakness classification (CWE)

CWE-639 — Authorization Bypass Through User-Controlled Key

References

cve@mitre.org (Exploit, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2018-18976?: CVE-2018-18976 is a medium-severity vulnerability in Ascensia Contour Diabetes, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 5.3/10. Published 2019-05-06.
How severe is CVE-2018-18976?: Medium severity. CVSS v3 base score is 5.3 out of 10.